Teva Recalls 580,000+ Prazosin Bottles Over Cancer-Causing Impurity

Prazosin Recall: Emerging Mass Tort Litigation

Teva Pharmaceuticals has recalled over 580,000 bottles of prazosin after detecting N-nitroso impurities, a type of contaminant linked to cancer. The first lawsuit has already been filed.

Recall Details

• 580,000+ bottles recalled by Teva Pharmaceuticals
• N-nitroso impurity detected - a known carcinogen
• 510,000 patients affected who are prescribed prazosin annually

Legal Action Begins

The first lawsuit was filed on October 23, 2025 in the Northern District of Georgia, marking the beginning of what could become a significant mass tort litigation.

What is Prazosin?

Prazosin is commonly prescribed for:

• High blood pressure (hypertension)
• PTSD-related nightmares
• Benign prostatic hyperplasia (BPH)

N-Nitroso Impurities

These impurities have been at the center of numerous drug recalls and lawsuits, including:

• Zantac (ranitidine)
• Valsartan
• Metformin

Do You Qualify for a Claim?

Viable claims typically require:

• Pharmacy records proving you received recalled lot numbers
• Documented cancer diagnosis potentially linked to the medication
• Evidence of exposure during the recall period

Next Steps

If you took prazosin and have been diagnosed with cancer, contact a legal professional immediately to preserve your rights and explore your legal options.